Skip to Main Content

Paper Details

The BRCA2 mutation status shapes the immune phenotype of prostate cancer.
Cancer Immunol Immunother
34
2019
Author NameAffiliation
Volker EndrisInstitute of Pathology, University of Heidelberg School of Medicine
Anna-Lena VolckmarInstitute of Pathology, University of Heidelberg School of Medicine
Holger S??ltmannNational Center for Tumor Diseases, German Cancer Research Center
Holger S??ltmann
Peter SchirmacherInstitute of Pathology, University of Heidelberg School of Medicine
Albrecht StenzingerInstitute of Pathology, University of Heidelberg School of Medicine
  • 1 - 6

Datasets

Release 1.2